Manchester United derrota a Arsenal y sigue a un punto del Chelsea

LONDRES (AFP) – Manchester United logró una convincente e importante victoria este domingo en terreno del Arsenal (3-1), con lo que sigue en segunda posición en la Premier League, tras la disputa de la 24ª jornada, a un punto del líder Chelsea, que el sábado ganó en campo del Burnley (2-1).

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission.

Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S.

securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements. We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext.

WASHINGTON (AFP) – El presidente estadounidense Barack Obama admitió el domingo, a casi un año de su llegada a la Casa Blanca, que él también tiene dudas y está decepcionado por la lentitud de los avances logrados.

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds.

The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc.

is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions.

Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements. We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext.

TOKIO (AFP) – Los fabricantes japoneses de bebidas, Kirin Holdings y Suntory, están a punto de llevar a cabo una fusión que conllevará el nacimiento de un gigante mundial más grande aún que la estadounidense Coca-Cola o la belga Anheuser-Busch InBev, publicó este jueves el diario económico Nikkei.

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement.

Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc.

is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S.

securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements. The Company does not undertake to update theseforward-looking statements. We disclaim any obligation to update any suchfactors or to publicly announce the result of any revisions to any of theforward-looking statements contained herein to reflect future results, eventsor developments except if we are requested by a governmental authority orapplicable law.SOURCEAETERNA ZENTARIS INC.Investor Relations: Ginette Vallieres, Investor Relations Coordinator, (418)652-8525 ext. 265, ; Media Relations: Paul Burroughs,Director of Communications, (418) 652-8525 ext. 406, .

VALENCIA, España (AFP) – El desafiante estadounidense BMW Oracle Racing, rotundo vencedor este domingo en Valencia (este) de la 33ª Copa del América de vela frente al defensor suizo Alinghi, ha devuelto la famosa Jarra de las Cien Guineas a Estados Unidos, que la buscaba desde 1995.

The FDA staff memo was released ahead of an advisory panelmeeting, scheduled for Tuesday, where outside experts willreview the safety of various drugs for children. Depakote was once a blockbuster for Abbott but salesdropped sharply after generic competitors became available.First-quarter sales for the drug were $110 million. “For many women, Depakote may be the only effectivemedicine to control their seizures” and doctors and patientsshould evaluate the drug’s risks versus its benefits, Powerssaid. At the same time webelieve that SanJiang will facilitate our ability to get all relatedlogistics in place and to obtain further land assets as needed.”ABOUT SANJIANG AGRICULTURE CO LTD.SanJiang Agriculture Co Ltd. We will provide thetechnology, know-how and management of the operation.

Under the Joint Venture,SanJiang will provide the land and factory buildings. Credit Agricole was also told by the antitrust not to take arole in corporate governance at Intesa Sanpaolo but under itsoriginal pact with Generali it did. The two suspended their original agreement until June 30 andare putting together a revised pact which they hope will satisfyantitrust authorities. TOUGH MEASURES? The source said on Friday that if the antitrust authorityreceived a formal request for an extension of the deadline tosell, it was likely to accept but impose restrictions on thestake. The authority granted an extension to Italy’s biggest bank,UniCredit (CRDI.MI) on selling 3.24 percent of Generali lastyear with the condition of suspending voting rights.

Intesa Sanpaolo could face a fine of up to 5 billion eurosfrom the antitrust, newspapers have reported, for failing toensure shareholders meet its requirements. On Friday, Intesa Sanpaolo’s chief executive, CorradoPassera, said its shareholders would find a solution if the bankfaced a fine. “Shareholders will find a solution which won’t createproblems for the bank,” Passera said on the sidelines of aconference in Milan He gave no further details. One analyst suggested Intesa Sanpaolo might try to share thepossible fine with Credit Agricole and Generali. Passera also confirmed the bank would soon take advantage ofgovernment-backed bonds aimed at boosting Italian banks’capital. Intesa shares were down 3.1 percent at 2.265 euros by 1422GMT while Credit Agricole was broadly flat The DJ Stoxx indexof banks .SX7P was up 0.91 percent (writing by Jo Winterbottom, Editing by Andy Bruce) Italy.

MADRID (AFP) – El entrenador del Barcelona, Josep Guardiola, reconoció este miércoles haberse “equivocado” al titularizar a demasiados suplentes en el partido de ida del martes de la Copa del Rey contra el Sevilla, que terminó con derrota en casa de los catalanes (2-1).

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds. The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission.

Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization. News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements.

Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements. Investors are cautioned not to rely on theseforward-looking statements.

PARÍS (AFP) – - El futuro de Renault en la Fórmula 1 se decide este lunes ante el Consejo Mundial de la Federación Internacional del Automóvil (FIA), que podría castigar duramente a la escudería, juzgada por un supuesto fraude en el Gran Premio de Singapur 2008.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner.

Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing.

For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide. Of these, 1,200 are employed in Germany,either at the KUKA Robot Group headquarters in Augsburg, or at varioussubsidiaries In 2008, sales totaled 474 million euro. Twenty-six subsidiariesprovide a presence in the major markets of Europe, America and Asia.The KUKA logo is a registered trademark of KUKA Roboter GmbH KUKA, is atrademark of KUKA Roboter GmbH. All other trademarks are owned by theirrespective companies.KUKA Robotics CorporationMedia ContactRebecca MarkelMarketing ManagerPhone: Business Wire 2009.

(Recasts on order against Google) Stocks  |  Media  |  China BEIJING, June 19 (Reuters) – China’s Internet watchdog onFriday ordered Google (GOOG.O) to stop overseas websites with”pornographic and vulgar” content from being accessed throughits Chinese-language search engine. The China Internet Illegal Information Reporting Centre hadtold Google to “make immediate changes” and clean up thecontent available through its search engine (),the official Xinhua news agency reported. The targetting of Google illustrates the difficulties facedby foreign Internet firms doing business in the world’s largestonline market while avoiding charges of censorship. In an emailed statement, Google said it met with governmentofficials to discuss the problem of “pornographic content andmaterial that is harmful to children on the web in China”. “We are undertaking a thorough review of our service andtaking all necessary steps to fix any problems with ourresults. We believe we have addressed a large majority of theproblem results,” the statement said. The order came a day after Chinese state television blastedGoogle and the centre denounced it for allowing “foreignInternet pornographic information”.

SAN FRANCISCO, EEUU (AFP) – - Google y Yahoo! se sumaron el martes a una creciente lista de proveedores de servicio de correo electrónico cuyos usuarios fueron engañados por piratas informáticos para revelar sus contraseñas.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner.

Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators.

KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide.

WASHINGTON (AFP) – Una ternera de un año que sufrió el congelamiento en sus patas traseras, que debieron ser amputadas, recibió dos prótesis colocadas por un equipo de veterinarios de la Universidad de Colorado, en la primera vez que se practica una intervención de este tipo.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner.

Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots.

The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing. For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide. Of these, 1,200 are employed in Germany,either at the KUKA Robot Group headquarters in Augsburg, or at varioussubsidiaries In 2008, sales totaled 474 million euro.

The reason for this is that there are many young and excellent players in the majors who are, for the most part, getting paid the league minimum.Prince Fielder, a four-season veteran in the majors just signed a contract worth $18 million with the Milwaukee Brewers; he also avoided salary arbitration. Con una variedad tan amplia de formas y sabores, ¡hacerdel postre una ocasión memorable nunca ha sido más fácil ni más seguro! Sinecesitan más información, los consumidores pueden visitar. Let me start by saying that I have supported Walter Smith and Sir David Murray through thick and thin but the potential sales of Kris Boyd and Barry Ferguson are definitely on the “thick” side, if looked on with any type of optimism.If the Ibrox club were going to get £10 million for the pair in some crazy deal, then sure, think about it but £3.5 million (Only £2.5 million of which is guaranteed) for Boyd and a further £2.5 million for our Captain, Ferguson, smacks of desperation.Are we really in such a hole that we have to sell our best players to smaller teams in smaller leagues every time we receive a semi-decent offer?Sadly, it appears so, and every Rangers fan should realise this and accept it.Kris Boyd has 21 goals in 23 games this season. (Reporting by Raissa Kasolowsky; Writing by John Irish andFirouz Sedarat; Editing by Andrew Macdonald) ($1=3.673 dirhams). They dropped easy interceptions.They played like a team that has a terrible head coach and a quarterback that even the 1985 Bears wouldn’t have been good enough to overcome.Meanwhile, Chad Pennington continued to play solid football. Includingthe specially serviced assets, 13 loans, representing 7.9% of the pool’soutstanding principal balance, have been designated Fitch Loans of Concern(LOCs) In 2009, 111 loans (87.0%) are scheduled to mature.

We should not have expected complete detailed accuracy and consistency in witnesses’ recollections of a fast-moving disorderly series of events.Phelan’s second signed written statement is dated 3 October 2008, more than 5 months after the events.Phelan’s first statement was written on May 17th 2008, three weeks after the incident. We have just become a part of the downward spiral of financial gain that combat sports seems to be involved in, from the ridiculous matchups in boxing to the over-the-top spectacles in mixed martial arts (such as EliteXC). * Provides historical and forecast data and information for all the majoroperating and planned crude oil and natural gas fields. Especially when the coaches and pollster seem to be split down the middle, why is ESPN leaning so hard one way? It obviously had an effect on the poll where OU lost quite a bit of points when they had the more impressive win of the two and beat a team on the road by more than the Longhorns beat them at home.I do not think ESPN favors Texas but they may favor the number of viewers in Texas. 12) ALABAMA                                                                            No. TeleNav Vehicle Manager helpscompanies of all sizes better manage their day-to-day fleet operations, reduceoperating costs and simplify regulatory compliance. Granted coming out of the last two games they had was not going to be easy, but the Michigan loss really stings them in terms of perception.

TORONTO, April 6 (Reuters) – ConocoPhillips (COP.N) said onMonday it reduced rates at its 238,000-barrel-per-day Baywayrefinery in Linden, New Jersey, after a fire early Sundaymorning in the crude distillate unit. We miss you, Tom. For all the talk about Jerod Mayo, (who has been great so far), Gary Guyton is an undrafted rookie free agent getting a lot of time on the field. With two weeks left, Papelbon has already thrown more innings than he did last season and will probably surpass his career high. We all can learn from theirexample.Of course, our nation has not always been immune to the impulse to sacrificethe timeless principles of the rule of law to the transient fears of themoment. With the Dodgers in town yesterday to start a series against the Nats, Teddy Roosevelt, everybody?s favorite lovable loser (you know, aside from the team itself), decided to put on the Manny wig for the Presidents Race.As always, the race didn?t end well for Teddy. Favre is not only recognized by sports fans but by the public in general.

* Includes a five-year forecast of the industry Highlights The global railroads sector grew by 3.4% in 2007 to reach a value of $658.1billion. French printing firm CPI went back to its banks in November2007 for a covenant waiver request, increasing margins on itsdebt, LPC reported at the time. * 6% decrease in color revenue2, with a 6-percentage point negative impact fromcurrency.  This small fact too many, proves a great one on the race track.

“Tripwire’s method for continuous complianceacross both physical and virtual environments is enabling it to fulfillthe market’s needs and helping the company gain share in the industry. Ourrecent survey of IT security buyers demonstrates Tripwire’s continuedexecution as it is viewed as one of the top strategic vendors in thespace.” (Pacific Crest / MetroSITE March 2009 Security Spending Survey)Unlike the experience of other technology companies in the region,Tripwire has grown its employee base by 22 percent in the last year andexpanded its executive expertise with the hire of Aaron Lerner, vicepresident of engineering. In addition, the company was once again honoredby Oregon Business Magazine as one of Oregon’s “100 Best Places to Work,”reflecting Tripwire’s reputation as an employer of choice as evidenced by95 percent employee retention. Other first quarter milestones include:–Announced a major new initiative for virtual infrastructure (VI)professionals, which includes Tripwire OpsCheck(TM), a free tool to manageVMware VMotion, and an online community for VI administrators,. Tripwire OpsCheck assesses common configuration problemsthat may prevent VMotion from operating properly, and providestroubleshooting tips for configuring VMotion based on Tripwire OpsChecktest results. To download Tripwire OpsCheck, go to Tripwire Express for PCI to market. Tripwire Express for PCIis an enhanced file integrity monitoring solution that enables smallerretailers to quickly achieve and maintain PCI compliance based on “pay asyou grow” pricing.–Unveiled Tripwire Remote Operations Service, a new services solutionthat provides complete remote administration and maintenance of TripwireEnterprise, ensuring consistency and performance, lowering customers’ TotalCost of Ownership of the system.–Introduced Tripwire Compliance Management Pack for Microsoft SystemCenter Operations Manager 2007.Customers who use both Tripwire Enterpriseand System Center Operations Manager 2007 in their IT operations will nowbe able to seamlessly manage policy from a single viewpoint, ensuringcontinuous compliance.

Tripwire released the Compliance Management Pack inFebruary 2009 to a select group of customers and already has 25 customersusing the integration successfully within their environment.–Tripwire’s Virtualization Evangelist, Stephen Beaver, was named aVMware vExpert, an award given to individuals who have significantlycontributed to the community of VMware users and helped spread the wordabout virtualization over the past year.”While we are fortunate to experience growth, expansion andrecognition in this economy, it is not by chance,” said Jim Johnson,President and CEO of Tripwire. “We have a team of driven employeesdedicated to expanding our legacy of market-leading research anddevelopment, and quickly responding to customer needs.”First quarter results continue the momentum of 2008, a banner year forTripwire, which resulted in revenue growth of 27 percent year over year,more than 6,550 customers, $62 million dollars in revenue, and $70.5million in recorded bookings. The company’s sustained growth has come fromits ability to proactively address market needs for IT security andcompliance, coupled with a strong commitment to customer success.About Tripwire, Inc.Tripwire helps over 6,500 enterprises worldwide reduce security risk,attain compliance and increase operational efficiency throughout theirvirtual and physical environments. Using Tripwire’s industry-leadingconfiguration assessment and change auditing solutions, organizationssuccessfully achieve and maintain IT configuration control Tripwire isheadquartered in Portland, Ore.

with offices worldwide. http:// BlomgrenTripwire503.276.7541Email ContactCopyright 2009, Market Wire, All rights reserved.-0-. * Ericsson says could put cash in Sony Ericsson if needed China  |  Japan * No comment on developments in equipment market in Q1 (Adds background, comment) STOCKHOLM, April 22 (Reuters) – Ericsson (ERICb.ST), theworld’s biggest mobile telecom equipment maker, said onWednesday it was ready to inject money into mobile phone jointventure Sony Ericsson if needed. Sony Ericsson, the world’s number 4 handset maker, reporteda pretax loss of 370 million euros ($478.2 million) in the firstquarter and repeated it saw the mobile phone market contractingat least 10 percent this year. “In the situation they are in today it is a natural measureto take that we plan for this so that we have the readiness ifit were necessary,” Chief Executive Carl-Henric Svanberg toldjournalists before the company’s annual general meeting. “Then we will consider things depending on how theoperations (Sony Ericsson) develop.” Sony Ericsson, a joint venture between Ericsson and Japan’sSony Corp (6758.T) plans to cut 2,000 jobs, around one-fifth ofits workforce this year. Svanberg said that Sony Ericsson was important to Ericssonbecause it allowed the company to understand what the end usersof its products want, allowing it to create end-to-end telecomssolutions.Svanberg declined to comment on further developments untilEricsson reports its first-quarter results on April 30. He said Ericsson was not particularly worried by a trendtoward network sharing by operators in Europe “We are not impacted particularly by this,” he said.

Telecoms markets are relatively well consolidated in theUnited States, Japan, and China, but Europe is still fragmented,Svanberg said. He said the biggest costs associated with network buildingwere sites, antennae, cables, batteries for example “On the other hand.. you need twice as much radio capacityin a shared net as you would in each of two separate networks.” Sweden’s Tele2 (TEL2b.ST) and Norway’s Telenor (TEL.OL) saidthis month they would build a joint fourth-generation network inSweden in a bid to cut costs.($1=.7738 euros)(Editing by Mike Nesbit) China Japan. Millennium Technology Value Partners Announces New Investments inBest-of-Breed Technology Companies- Facebook, Zappos, eHarmony, LiveOps, DataPipe, Fonality, and ReardenCommerce are among New Portfolio Companies- “Secondary Market is Open for Business, Even in the Midst of the FinancialCrisis”NEW YORK, April 22 /PRNewswire/ — Millennium Technology Value Partners, L.P.,a private equity fund specializing in providing liquidity solutions to holdersof illiquid private company securities, announced today that it had recentlyadded investments in 9 new companies to its portfolio. Millennium now hasinvested in 26 best-of-breed technology and high-growth companies through itsfund, Millennium Technology Value Partners, L.P., which held its final closethree years ago. Among the new portfolio companies are Facebook, the world’sleading social media company, Zappos, one of the world’s leading e-commercecompanies, eHarmony, the #1 trusted relationship site, LiveOps, the leader inon-demand contact center solutions, Fonality, a leader in open source businessphone systems, DataPipe, a leading data center and managed services companywith a worldwide presence, and Rearden Commerce, the creator of an innovativeonline personal assistant.

MADRID (AFP) – - El presidente de la líder eléctrica española Endesa, Borja Prado, se reunió con la presidenta chilena, Michelle Bachelet, en su primera visita al país, donde proyecta cinco centrales hidroeléctricas que denuncian los ecologistas por los daños que causará a la Patagonia.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases.

KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing.

WASHINGTON (AFP) – - El Banco Mundial (BM) aprobó el martes un préstamo de 1.504 millones de dólares para financiar políticas de reducción de gases contaminantes en México, otro de 150 millones para un proyecto de transporte urbano en Argentina y otro más de 29,9 millones para un programa de escuelas a tiempo completo en Uruguay.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner.

Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators. KUKA robots are utilized in many different facets of the robotics industry fromautomotive, aerospace, consumer goods, logistics, food, pharmaceutical, medical,foundry and plastics industries and in multiple applications including materialhandling, packaging, palletizing, welding and surface finishing.

For moreinformation contact KUKA Robotics at 866-873-5852 or visit their website at. About the KUKA Robot GroupKUKA Roboter GmbH, Augsburg, is a member of the KUKA Aktiengesellschaft andranks among the world`s leading suppliers of industrial robots. Corecompetencies are the development, production and sale of industrial robots,controllers, software and linear units. The company is the market leader inGermany and Europe, and the number three in the world The KUKA Robot Groupemploys about 2,200 people worldwide.

Of these, 1,200 are employed in Germany,either at the KUKA Robot Group headquarters in Augsburg, or at varioussubsidiaries In 2008, sales totaled 474 million euro. Twenty-six subsidiariesprovide a presence in the major markets of Europe, America and Asia.The KUKA logo is a registered trademark of KUKA Roboter GmbH KUKA, is atrademark of KUKA Roboter GmbH. All other trademarks are owned by theirrespective companies.KUKA Robotics CorporationMedia ContactRebecca MarkelMarketing ManagerPhone: Business Wire 2009. (Recasts on order against Google) Stocks  |  Media  |  China BEIJING, June 19 (Reuters) – China’s Internet watchdog onFriday ordered Google (GOOG.O) to stop overseas websites with”pornographic and vulgar” content from being accessed throughits Chinese-language search engine. The China Internet Illegal Information Reporting Centre hadtold Google to “make immediate changes” and clean up thecontent available through its search engine (),the official Xinhua news agency reported. The targetting of Google illustrates the difficulties facedby foreign Internet firms doing business in the world’s largestonline market while avoiding charges of censorship.

A BORDO DEL AIR FORCE ONE (AFP) – El presidente de EEUU, Barack Obama, ha pedido a China “algunas respuestas” sobre los ciberataques sufridos por el gigante de Internet norteamericano Google, sumándose así a la última disputa entre Pekín y Washington por un tema de libertades.

(NASDAQ:AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrinetherapy and oncology, announced today that it has received commitments topurchase US$10 million of units comprised of common shares and common sharepurchase warrants in a registered direct offering. AEterna Zentaris expects toreceive net proceeds of approximately US$9.25 million after deductingplacement agent fees and other offering expenses. Under the terms of aSecurities Purchase Agreement, the Company will sell to such institutionalinvestors an aggregate of 5,319,149 common shares of its capital at a price ofUS$1.88 per share and issue warrants to acquire an aggregate of 1,861,702common shares at an exercise price of US$2.06 per share.The warrants to purchase additional common shares of AEterna Zentaris will beexercisable beginning three months after issuance and will expire 30 monthsafter issuance. All of the common shares and warrants were offered pursuant toan effective shelf registration statement. Proceeds from the transaction willbe used for general corporate purposes, including clinical development of ourleading oncology and endocrinology compounds.

The offering is expected to beconsummated no later than June 24, 2009, subject to customary closingconditions.Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.,(Nasdaq: RODM ( )), acted as the exclusiveplacement agent for the transaction. The placement agent will receivethirty-month warrants, exercisable beginning six months after issuance, topurchase 287,234 common shares at US$2.35 per share.In connection with the offering, the Company will file a prospectus supplementto its existing base shelf prospectus with the Canadian securities regulatoryauthorities and with the Securities and Exchange Commission. Copies of theprospectus supplement and accompanying prospectus may be obtained directlyfrom the Company or by contacting AEterna Zentaris Inc., 1405 duParc-Technologique Boulevard, Quebec City, Canada G1P 4P5.This press release shall not constitute an offer to sell or a solicitation ofan offer to buy any securities nor shall there be any sale of such securitiesin any jurisdiction in which such offer, solicitation or sale would beunlawful prior to registration or qualification under the securities laws ofany such jurisdiction. This offering is being made by means of a prospectussupplement to the Company’s existing base prospectus that is part of its shelfregistration statement previously filed with and declared effective by theSecurities and Exchange Commission.About AEterna Zentaris Inc.AEterna Zentaris Inc. is a global biopharmaceutical company focused onendocrine therapy and oncology, with proven expertise in drug discovery,development and commercialization.

News releases and additional informationare available at StatementsThis press release contains forward-looking statements made pursuant to thesafe harbor provisions of the U.S. Securities Litigation Reform Act of 1995.Forward-looking statements involve known and unknown risks and uncertainties,which could cause the Company’s actual results to differ materially from thosein the forward-looking statements. Such risks and uncertainties include, amongothers, the availability of funds and resources to pursue R&D projects, thesuccessful and timely completion of clinical studies, the ability of theCompany to take advantage of business opportunities in the pharmaceuticalindustry, uncertainties related to the regulatory process and general changesin economic conditions. Investors should consult the Company’s quarterly andannual filings with the Canadian and U.S. securities commissions foradditional information on risks and uncertainties relating to theforward-looking statements.

DOHA (AFP) – La Convención sobre el Comercio Internacional de Especies de Fauna y Flora Salvajes en Peligro de Extinción (CITES, por sus siglas en inglés) pidió el sábado más medios para preservar la vida salvaje, al iniciar una reunión en Doha, donde examinará la suerte de especies emblemáticas, como el atún rojo del Mediterráneo.

The industrialend-user segment is also emerging as a significant source of retrofits, as plantowners have been investing in capacity expansions, new expansions, andrefurbishing aging power generation plants to improve productivity. Industrieshad invested substantially in brown field projects and maintenance and capacityreplacement in 2007, providing relief to gasket manufacturers. Although the economic slump is likely to defer a few industrial projects thatwere to be taken up in 2009 and 2010, the already initiated ones will go a longway in shoring up the gaskets market. The postponement of oil and gas expansionprojects will also curb the rapid growth of the market until 2010. “Decreasingoil prices are expected to reduce capacities until 2010, but with marketstabilization, the refurbishment of existing plants becomes necessary,” says theanalyst of this research. “The aftermarket business will see the gaskets marketsgrow moderately during this period.” Acknowledging the challenge of operating inthese difficult economic environments, companies all over the world are strivingto lower operational expenditure and improve returns on investment.

With manycompanies also looking to considerably downsize maintenance personnel forequipment repair or breakdown, there is a large market for products that offerbetter reliability and life cycle cost benefits. DUBLIN–(Business Wire)–Research and Markets( http://) hasannounced the addition of the “Three Case Studies in Technology Innovation(Apple, Google, Pixar)” report to their offering. This bundled report contains three innovation case studies, and focus on theinnovation efforts of Apple, Google, and Pixar. These three companies haveconsistently defined the cutting-edge in technology. In the Apple case study, learn how the company has re-emerged as one of theworld’s most innovative companies.

Apple has managed to sustain its innovationefforts with calculated, consistent increases in R&D spending and rapid-firelaunches of new products and upgrades. Learn how Apple’s success has beenbecause the company has deliberately focused its efforts on generating betterideas faster. In the Google case study, we take a look at their range of jaw-dropping productsand services that seem to literally tumble out of their innovation pipeline -Google Maps, Google Talk, and Google Page Creator to name just a few All ofthis innovation is backed by results. How do they manage to be so innovative -so consistently? Pixar is best known for its impressive track record of hit family movies,including: Toy Story 2, Finding Nemo, and The Incredibles. Pixar’s last sixmovies have grossed more than $3 billion in worldwide box office receipts, andPixar’s creative team members have won awards including Oscars, Gold Clios,Golden Globes and Grammys.

NUEVA YORK (AFP) – - Por segunda ocasión la lluvia obligó a la suspensión momentánea del partido de cuartos de final de tenis en el US Open que disputa este jueves el español Rafael Nadal (N.3) con el chileno Fernando González (N.11).

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers.

This same solution could be used for material handling to pick randombottles and load cases. KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots.

HONG KONG (AFP) – - El Banco Asiático del Desarrollo (BAsD) aumentó el martes al 3,9% su previsión de crecimiento de Asia en el año 2009, contra el 3,4% que había previsto inicialmente en marzo, y atribuyó este incremento a los planes de reactivación impulsados por los gobiernos.

The KR 16will be executing dry tool paths of the waterjet process around complex 3D partswith quick change tooling ability to demonstrate milling, drilling, and materialhandling. The quick tool changing function uses KUKA`s hand teach device,allowing for automatic tool change function and enabling the user to teach atool path manually using a joystick while utilizing KUKA safe robot technology.The KR16 robotic cell demonstration was designed and supplied by FlowInternational Corporation. In a robotic cell designed and supplied by Official KUKA Robotics SystemPartner, Dyco Inc. the flexible, fast handling KR5 Sixx will be demonstratedutilizing a vision system. The vision system enables the KR5 Sixx to locate andpick random plastic bottles from a moving conveyor belt simulating loading puckcarriers. This same solution could be used for material handling to pick randombottles and load cases.

KUKA Robotics will also display a KR5 Arc in a demo cell designed and suppliedby Electro-Hydraulic Automation an Official KUKA Robotics System Partner. Thedemo cell shows the highly versatile KR5 ARC holding an air powered cutting toolto trim and cut holes in plastics parts, simulating the cuts used in vehicledashboard openings. KUKA Robotics will display an injection molding extraction cell using the KR5Sixx. The KR5 Sixx features the flexibility of variable mounting options offloor or ceiling along with fast handling capabilities, will simulate theextraction of medical syringes from an injection molding machine. The KUKA Robotics System Partner network is designed to mutually benefit eachorganization`s users by extending the way customers can access tailoredsolutions from experienced system partners with the major competitive andtechnological advantage of high precision KUKA robots. The KUKA Robotics SystemPartner Network includes experienced system builders, system providers,application specialists and expert robot integrators.